EX-23.2 4 exhibit_23-2.htm EXHIBIT 23.2

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

The Board of Directors
Chemomab Therapeutics Ltd. (formerly Anchiano Therapeutics Ltd.):

We consent to the use of our report dated March 16, 2021, with respect to the financial statements of Chemomab Ltd. incorporated herein by reference.

/s/ Somekh Chaikin

Somekh Chaikin

Certified Public Accountants (lsr.)

Member Firm of KPMG International

Tel Aviv, Israel September 13, 2021